Kirk Christopher J. 4
4 · Kezar Life Sciences, Inc. · Filed Nov 9, 2023
Insider Transaction Report
Form 4
Kirk Christopher J.
DirectorCEO
Transactions
- Award
Employee Stock Option (right to buy)
2023-11-08+875,000→ 875,000 totalExercise: $0.84Exp: 2033-11-07→ Common Stock (875,000 underlying)
Footnotes (1)
- [F1]One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on December 7, 2023, subject to the Reporting Person continuing to provide service through each such date.